nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—Doxazosin—Donepezil—Alzheimer's disease	0.781	1	CrCrCtD
Terazosin—Prazosin—MT3—Alzheimer's disease	0.00344	0.888	CrCbGaD
Terazosin—KCNH6—forebrain—Alzheimer's disease	0.00277	0.0813	CbGeAlD
Terazosin—KCNH6—telencephalon—Alzheimer's disease	0.00255	0.0748	CbGeAlD
Terazosin—KCNH7—nervous system—Alzheimer's disease	0.00211	0.0619	CbGeAlD
Terazosin—KCNH7—central nervous system—Alzheimer's disease	0.00203	0.0596	CbGeAlD
Terazosin—KCNH7—cerebellum—Alzheimer's disease	0.00199	0.0583	CbGeAlD
Terazosin—KCNH7—brain—Alzheimer's disease	0.00161	0.0474	CbGeAlD
Terazosin—ADRA1D—forebrain—Alzheimer's disease	0.00153	0.045	CbGeAlD
Terazosin—KCNH6—nervous system—Alzheimer's disease	0.0015	0.0441	CbGeAlD
Terazosin—KCNH6—central nervous system—Alzheimer's disease	0.00145	0.0425	CbGeAlD
Terazosin—ADRA1D—telencephalon—Alzheimer's disease	0.00141	0.0414	CbGeAlD
Terazosin—KCNH6—brain—Alzheimer's disease	0.00115	0.0337	CbGeAlD
Terazosin—ADRA1A—forebrain—Alzheimer's disease	0.000882	0.0259	CbGeAlD
Terazosin—ADRA1B—nervous system—Alzheimer's disease	0.000852	0.025	CbGeAlD
Terazosin—KCNH2—forebrain—Alzheimer's disease	0.000851	0.025	CbGeAlD
Terazosin—ADRA1D—nervous system—Alzheimer's disease	0.000833	0.0245	CbGeAlD
Terazosin—ADRA1B—central nervous system—Alzheimer's disease	0.00082	0.0241	CbGeAlD
Terazosin—ADRA1A—telencephalon—Alzheimer's disease	0.000811	0.0238	CbGeAlD
Terazosin—ADRA1D—central nervous system—Alzheimer's disease	0.000802	0.0235	CbGeAlD
Terazosin—KCNH2—telencephalon—Alzheimer's disease	0.000783	0.023	CbGeAlD
Terazosin—ABCB1—blood vessel—Alzheimer's disease	0.000708	0.0208	CbGeAlD
Terazosin—ADRA1B—brain—Alzheimer's disease	0.000651	0.0191	CbGeAlD
Terazosin—ADRA1D—brain—Alzheimer's disease	0.000637	0.0187	CbGeAlD
Terazosin—Urinary tract infection—Donepezil—Alzheimer's disease	0.000484	0.00333	CcSEcCtD
Terazosin—Conjunctivitis—Donepezil—Alzheimer's disease	0.000484	0.00333	CcSEcCtD
Terazosin—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000484	0.00333	CcSEcCtD
Terazosin—ADRA1A—nervous system—Alzheimer's disease	0.000479	0.014	CbGeAlD
Terazosin—Sweating—Donepezil—Alzheimer's disease	0.000478	0.00329	CcSEcCtD
Terazosin—Bronchitis—Rivastigmine—Alzheimer's disease	0.000477	0.00328	CcSEcCtD
Terazosin—Dysuria—Memantine—Alzheimer's disease	0.000474	0.00326	CcSEcCtD
Terazosin—Vision blurred—Galantamine—Alzheimer's disease	0.000474	0.00326	CcSEcCtD
Terazosin—Tremor—Galantamine—Alzheimer's disease	0.000471	0.00324	CcSEcCtD
Terazosin—Epistaxis—Donepezil—Alzheimer's disease	0.00047	0.00323	CcSEcCtD
Terazosin—Pollakiuria—Memantine—Alzheimer's disease	0.000469	0.00322	CcSEcCtD
Terazosin—Erectile dysfunction—Memantine—Alzheimer's disease	0.000467	0.00322	CcSEcCtD
Terazosin—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000466	0.00321	CcSEcCtD
Terazosin—Dysuria—Rivastigmine—Alzheimer's disease	0.000464	0.00319	CcSEcCtD
Terazosin—KCNH2—nervous system—Alzheimer's disease	0.000462	0.0136	CbGeAlD
Terazosin—Weight increased—Memantine—Alzheimer's disease	0.000462	0.00318	CcSEcCtD
Terazosin—ADRA1A—central nervous system—Alzheimer's disease	0.000461	0.0135	CbGeAlD
Terazosin—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000459	0.00315	CcSEcCtD
Terazosin—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000457	0.00315	CcSEcCtD
Terazosin—Malaise—Galantamine—Alzheimer's disease	0.000453	0.00312	CcSEcCtD
Terazosin—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000453	0.00312	CcSEcCtD
Terazosin—Weight increased—Rivastigmine—Alzheimer's disease	0.000452	0.00311	CcSEcCtD
Terazosin—Vertigo—Galantamine—Alzheimer's disease	0.000451	0.00311	CcSEcCtD
Terazosin—Depression—Memantine—Alzheimer's disease	0.000451	0.0031	CcSEcCtD
Terazosin—Syncope—Galantamine—Alzheimer's disease	0.000451	0.0031	CcSEcCtD
Terazosin—ADRA1A—cerebellum—Alzheimer's disease	0.00045	0.0132	CbGeAlD
Terazosin—Rhinitis—Donepezil—Alzheimer's disease	0.000448	0.00309	CcSEcCtD
Terazosin—KCNH2—central nervous system—Alzheimer's disease	0.000445	0.0131	CbGeAlD
Terazosin—Palpitations—Galantamine—Alzheimer's disease	0.000444	0.00305	CcSEcCtD
Terazosin—Pharyngitis—Donepezil—Alzheimer's disease	0.000444	0.00305	CcSEcCtD
Terazosin—Loss of consciousness—Galantamine—Alzheimer's disease	0.000442	0.00304	CcSEcCtD
Terazosin—Depression—Rivastigmine—Alzheimer's disease	0.000441	0.00304	CcSEcCtD
Terazosin—Oedema peripheral—Donepezil—Alzheimer's disease	0.000441	0.00303	CcSEcCtD
Terazosin—Conjunctivitis—Memantine—Alzheimer's disease	0.00044	0.00303	CcSEcCtD
Terazosin—Urinary tract infection—Memantine—Alzheimer's disease	0.00044	0.00303	CcSEcCtD
Terazosin—Cough—Galantamine—Alzheimer's disease	0.000438	0.00302	CcSEcCtD
Terazosin—Convulsion—Galantamine—Alzheimer's disease	0.000435	0.003	CcSEcCtD
Terazosin—KCNH2—cerebellum—Alzheimer's disease	0.000435	0.0128	CbGeAlD
Terazosin—Doxazosin—CYP2D6—Alzheimer's disease	0.000432	0.112	CrCbGaD
Terazosin—Visual impairment—Donepezil—Alzheimer's disease	0.000431	0.00297	CcSEcCtD
Terazosin—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00043	0.00296	CcSEcCtD
Terazosin—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00043	0.00296	CcSEcCtD
Terazosin—Arthralgia—Galantamine—Alzheimer's disease	0.000428	0.00294	CcSEcCtD
Terazosin—Myalgia—Galantamine—Alzheimer's disease	0.000428	0.00294	CcSEcCtD
Terazosin—Chest pain—Galantamine—Alzheimer's disease	0.000428	0.00294	CcSEcCtD
Terazosin—Epistaxis—Memantine—Alzheimer's disease	0.000427	0.00294	CcSEcCtD
Terazosin—Anxiety—Galantamine—Alzheimer's disease	0.000426	0.00293	CcSEcCtD
Terazosin—Sinusitis—Memantine—Alzheimer's disease	0.000424	0.00292	CcSEcCtD
Terazosin—Sweating—Rivastigmine—Alzheimer's disease	0.000424	0.00292	CcSEcCtD
Terazosin—Discomfort—Galantamine—Alzheimer's disease	0.000423	0.00291	CcSEcCtD
Terazosin—ABCB1—embryo—Alzheimer's disease	0.000422	0.0124	CbGeAlD
Terazosin—Dry mouth—Galantamine—Alzheimer's disease	0.000418	0.00288	CcSEcCtD
Terazosin—Epistaxis—Rivastigmine—Alzheimer's disease	0.000417	0.00287	CcSEcCtD
Terazosin—Tinnitus—Donepezil—Alzheimer's disease	0.000417	0.00287	CcSEcCtD
Terazosin—Sinusitis—Rivastigmine—Alzheimer's disease	0.000415	0.00286	CcSEcCtD
Terazosin—Confusional state—Galantamine—Alzheimer's disease	0.000413	0.00284	CcSEcCtD
Terazosin—Rhinitis—Memantine—Alzheimer's disease	0.000407	0.0028	CcSEcCtD
Terazosin—Shock—Galantamine—Alzheimer's disease	0.000403	0.00278	CcSEcCtD
Terazosin—Pharyngitis—Memantine—Alzheimer's disease	0.000403	0.00277	CcSEcCtD
Terazosin—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000401	0.00276	CcSEcCtD
Terazosin—Tachycardia—Galantamine—Alzheimer's disease	0.0004	0.00275	CcSEcCtD
Terazosin—Oedema peripheral—Memantine—Alzheimer's disease	0.0004	0.00275	CcSEcCtD
Terazosin—Arrhythmia—Donepezil—Alzheimer's disease	0.0004	0.00275	CcSEcCtD
Terazosin—Rhinitis—Rivastigmine—Alzheimer's disease	0.000398	0.00274	CcSEcCtD
Terazosin—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000396	0.00273	CcSEcCtD
Terazosin—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000394	0.00271	CcSEcCtD
Terazosin—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000391	0.00269	CcSEcCtD
Terazosin—Visual impairment—Memantine—Alzheimer's disease	0.000391	0.00269	CcSEcCtD
Terazosin—Anorexia—Galantamine—Alzheimer's disease	0.000391	0.00269	CcSEcCtD
Terazosin—Malnutrition—Donepezil—Alzheimer's disease	0.000389	0.00268	CcSEcCtD
Terazosin—Flatulence—Donepezil—Alzheimer's disease	0.000384	0.00264	CcSEcCtD
Terazosin—Hypotension—Galantamine—Alzheimer's disease	0.000383	0.00264	CcSEcCtD
Terazosin—Visual impairment—Rivastigmine—Alzheimer's disease	0.000383	0.00263	CcSEcCtD
Terazosin—Tension—Donepezil—Alzheimer's disease	0.000382	0.00263	CcSEcCtD
Terazosin—Dysgeusia—Donepezil—Alzheimer's disease	0.000381	0.00262	CcSEcCtD
Terazosin—Eye disorder—Memantine—Alzheimer's disease	0.00038	0.00261	CcSEcCtD
Terazosin—Tinnitus—Memantine—Alzheimer's disease	0.000379	0.00261	CcSEcCtD
Terazosin—Nervousness—Donepezil—Alzheimer's disease	0.000378	0.0026	CcSEcCtD
Terazosin—Back pain—Donepezil—Alzheimer's disease	0.000377	0.00259	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000374	0.00257	CcSEcCtD
Terazosin—ABCB1—forebrain—Alzheimer's disease	0.000374	0.011	CbGeAlD
Terazosin—Eye disorder—Rivastigmine—Alzheimer's disease	0.000371	0.00255	CcSEcCtD
Terazosin—Insomnia—Galantamine—Alzheimer's disease	0.000371	0.00255	CcSEcCtD
Terazosin—Tinnitus—Rivastigmine—Alzheimer's disease	0.00037	0.00255	CcSEcCtD
Terazosin—Paraesthesia—Galantamine—Alzheimer's disease	0.000368	0.00253	CcSEcCtD
Terazosin—Vision blurred—Donepezil—Alzheimer's disease	0.000367	0.00252	CcSEcCtD
Terazosin—ADRA1A—brain—Alzheimer's disease	0.000366	0.0107	CbGeAlD
Terazosin—Tremor—Donepezil—Alzheimer's disease	0.000365	0.00251	CcSEcCtD
Terazosin—Somnolence—Galantamine—Alzheimer's disease	0.000365	0.00251	CcSEcCtD
Terazosin—Arrhythmia—Memantine—Alzheimer's disease	0.000363	0.0025	CcSEcCtD
Terazosin—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000361	0.00249	CcSEcCtD
Terazosin—Dyspepsia—Galantamine—Alzheimer's disease	0.000361	0.00248	CcSEcCtD
Terazosin—Decreased appetite—Galantamine—Alzheimer's disease	0.000356	0.00245	CcSEcCtD
Terazosin—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000355	0.00244	CcSEcCtD
Terazosin—Malnutrition—Memantine—Alzheimer's disease	0.000354	0.00243	CcSEcCtD
Terazosin—Fatigue—Galantamine—Alzheimer's disease	0.000354	0.00243	CcSEcCtD
Terazosin—KCNH2—brain—Alzheimer's disease	0.000353	0.0104	CbGeAlD
Terazosin—Malaise—Donepezil—Alzheimer's disease	0.000351	0.00242	CcSEcCtD
Terazosin—Constipation—Galantamine—Alzheimer's disease	0.000351	0.00241	CcSEcCtD
Terazosin—Vertigo—Donepezil—Alzheimer's disease	0.00035	0.00241	CcSEcCtD
Terazosin—Syncope—Donepezil—Alzheimer's disease	0.000349	0.0024	CcSEcCtD
Terazosin—Flatulence—Memantine—Alzheimer's disease	0.000348	0.0024	CcSEcCtD
Terazosin—Tension—Memantine—Alzheimer's disease	0.000347	0.00239	CcSEcCtD
Terazosin—Dysgeusia—Memantine—Alzheimer's disease	0.000346	0.00238	CcSEcCtD
Terazosin—Malnutrition—Rivastigmine—Alzheimer's disease	0.000346	0.00238	CcSEcCtD
Terazosin—ABCB1—telencephalon—Alzheimer's disease	0.000343	0.0101	CbGeAlD
Terazosin—Nervousness—Memantine—Alzheimer's disease	0.000343	0.00236	CcSEcCtD
Terazosin—Loss of consciousness—Donepezil—Alzheimer's disease	0.000342	0.00235	CcSEcCtD
Terazosin—Back pain—Memantine—Alzheimer's disease	0.000342	0.00235	CcSEcCtD
Terazosin—Flatulence—Rivastigmine—Alzheimer's disease	0.000341	0.00234	CcSEcCtD
Terazosin—Cough—Donepezil—Alzheimer's disease	0.00034	0.00234	CcSEcCtD
Terazosin—Tension—Rivastigmine—Alzheimer's disease	0.000339	0.00234	CcSEcCtD
Terazosin—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000339	0.00233	CcSEcCtD
Terazosin—Feeling abnormal—Galantamine—Alzheimer's disease	0.000338	0.00232	CcSEcCtD
Terazosin—Convulsion—Donepezil—Alzheimer's disease	0.000337	0.00232	CcSEcCtD
Terazosin—Nervousness—Rivastigmine—Alzheimer's disease	0.000336	0.00231	CcSEcCtD
Terazosin—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000335	0.00231	CcSEcCtD
Terazosin—Back pain—Rivastigmine—Alzheimer's disease	0.000335	0.0023	CcSEcCtD
Terazosin—Vision blurred—Memantine—Alzheimer's disease	0.000333	0.00229	CcSEcCtD
Terazosin—Chest pain—Donepezil—Alzheimer's disease	0.000332	0.00228	CcSEcCtD
Terazosin—Arthralgia—Donepezil—Alzheimer's disease	0.000332	0.00228	CcSEcCtD
Terazosin—Myalgia—Donepezil—Alzheimer's disease	0.000332	0.00228	CcSEcCtD
Terazosin—Tremor—Memantine—Alzheimer's disease	0.000331	0.00228	CcSEcCtD
Terazosin—Anxiety—Donepezil—Alzheimer's disease	0.00033	0.00227	CcSEcCtD
Terazosin—Ill-defined disorder—Memantine—Alzheimer's disease	0.000328	0.00226	CcSEcCtD
Terazosin—Discomfort—Donepezil—Alzheimer's disease	0.000328	0.00225	CcSEcCtD
Terazosin—Vision blurred—Rivastigmine—Alzheimer's disease	0.000326	0.00224	CcSEcCtD
Terazosin—Dry mouth—Donepezil—Alzheimer's disease	0.000324	0.00223	CcSEcCtD
Terazosin—Body temperature increased—Galantamine—Alzheimer's disease	0.000324	0.00223	CcSEcCtD
Terazosin—Abdominal pain—Galantamine—Alzheimer's disease	0.000324	0.00223	CcSEcCtD
Terazosin—Tremor—Rivastigmine—Alzheimer's disease	0.000324	0.00223	CcSEcCtD
Terazosin—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000321	0.00221	CcSEcCtD
Terazosin—Confusional state—Donepezil—Alzheimer's disease	0.00032	0.0022	CcSEcCtD
Terazosin—Malaise—Memantine—Alzheimer's disease	0.000319	0.00219	CcSEcCtD
Terazosin—Oedema—Donepezil—Alzheimer's disease	0.000318	0.00219	CcSEcCtD
Terazosin—Vertigo—Memantine—Alzheimer's disease	0.000318	0.00219	CcSEcCtD
Terazosin—Syncope—Memantine—Alzheimer's disease	0.000317	0.00218	CcSEcCtD
Terazosin—Shock—Donepezil—Alzheimer's disease	0.000313	0.00215	CcSEcCtD
Terazosin—Palpitations—Memantine—Alzheimer's disease	0.000312	0.00215	CcSEcCtD
Terazosin—Malaise—Rivastigmine—Alzheimer's disease	0.000312	0.00215	CcSEcCtD
Terazosin—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000311	0.00214	CcSEcCtD
Terazosin—Vertigo—Rivastigmine—Alzheimer's disease	0.000311	0.00214	CcSEcCtD
Terazosin—Loss of consciousness—Memantine—Alzheimer's disease	0.000311	0.00214	CcSEcCtD
Terazosin—Syncope—Rivastigmine—Alzheimer's disease	0.00031	0.00213	CcSEcCtD
Terazosin—Cough—Memantine—Alzheimer's disease	0.000309	0.00212	CcSEcCtD
Terazosin—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000307	0.00211	CcSEcCtD
Terazosin—Convulsion—Memantine—Alzheimer's disease	0.000306	0.00211	CcSEcCtD
Terazosin—Palpitations—Rivastigmine—Alzheimer's disease	0.000306	0.0021	CcSEcCtD
Terazosin—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000304	0.00209	CcSEcCtD
Terazosin—Anorexia—Donepezil—Alzheimer's disease	0.000303	0.00208	CcSEcCtD
Terazosin—Hypersensitivity—Galantamine—Alzheimer's disease	0.000302	0.00208	CcSEcCtD
Terazosin—Cough—Rivastigmine—Alzheimer's disease	0.000302	0.00208	CcSEcCtD
Terazosin—Arthralgia—Memantine—Alzheimer's disease	0.000301	0.00207	CcSEcCtD
Terazosin—Myalgia—Memantine—Alzheimer's disease	0.000301	0.00207	CcSEcCtD
Terazosin—Chest pain—Memantine—Alzheimer's disease	0.000301	0.00207	CcSEcCtD
Terazosin—Anxiety—Memantine—Alzheimer's disease	0.0003	0.00206	CcSEcCtD
Terazosin—Convulsion—Rivastigmine—Alzheimer's disease	0.0003	0.00206	CcSEcCtD
Terazosin—Discomfort—Memantine—Alzheimer's disease	0.000297	0.00205	CcSEcCtD
Terazosin—Hypotension—Donepezil—Alzheimer's disease	0.000297	0.00204	CcSEcCtD
Terazosin—Arthralgia—Rivastigmine—Alzheimer's disease	0.000294	0.00203	CcSEcCtD
Terazosin—Chest pain—Rivastigmine—Alzheimer's disease	0.000294	0.00203	CcSEcCtD
Terazosin—Myalgia—Rivastigmine—Alzheimer's disease	0.000294	0.00203	CcSEcCtD
Terazosin—Dry mouth—Memantine—Alzheimer's disease	0.000294	0.00203	CcSEcCtD
Terazosin—Asthenia—Galantamine—Alzheimer's disease	0.000294	0.00202	CcSEcCtD
Terazosin—Anxiety—Rivastigmine—Alzheimer's disease	0.000293	0.00202	CcSEcCtD
Terazosin—Confusional state—Memantine—Alzheimer's disease	0.000291	0.002	CcSEcCtD
Terazosin—Discomfort—Rivastigmine—Alzheimer's disease	0.000291	0.002	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00029	0.00199	CcSEcCtD
Terazosin—Oedema—Memantine—Alzheimer's disease	0.000289	0.00199	CcSEcCtD
Terazosin—Dry mouth—Rivastigmine—Alzheimer's disease	0.000288	0.00198	CcSEcCtD
Terazosin—Insomnia—Donepezil—Alzheimer's disease	0.000287	0.00198	CcSEcCtD
Terazosin—Paraesthesia—Donepezil—Alzheimer's disease	0.000285	0.00196	CcSEcCtD
Terazosin—Confusional state—Rivastigmine—Alzheimer's disease	0.000285	0.00196	CcSEcCtD
Terazosin—Shock—Memantine—Alzheimer's disease	0.000284	0.00195	CcSEcCtD
Terazosin—Dyspnoea—Donepezil—Alzheimer's disease	0.000283	0.00195	CcSEcCtD
Terazosin—Somnolence—Donepezil—Alzheimer's disease	0.000283	0.00194	CcSEcCtD
Terazosin—Thrombocytopenia—Memantine—Alzheimer's disease	0.000283	0.00194	CcSEcCtD
Terazosin—Oedema—Rivastigmine—Alzheimer's disease	0.000282	0.00194	CcSEcCtD
Terazosin—Tachycardia—Memantine—Alzheimer's disease	0.000282	0.00194	CcSEcCtD
Terazosin—Diarrhoea—Galantamine—Alzheimer's disease	0.000281	0.00193	CcSEcCtD
Terazosin—Dyspepsia—Donepezil—Alzheimer's disease	0.00028	0.00192	CcSEcCtD
Terazosin—Hyperhidrosis—Memantine—Alzheimer's disease	0.000279	0.00192	CcSEcCtD
Terazosin—Shock—Rivastigmine—Alzheimer's disease	0.000278	0.00191	CcSEcCtD
Terazosin—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000276	0.0019	CcSEcCtD
Terazosin—Decreased appetite—Donepezil—Alzheimer's disease	0.000276	0.0019	CcSEcCtD
Terazosin—Tachycardia—Rivastigmine—Alzheimer's disease	0.000275	0.0019	CcSEcCtD
Terazosin—Anorexia—Memantine—Alzheimer's disease	0.000275	0.00189	CcSEcCtD
Terazosin—Fatigue—Donepezil—Alzheimer's disease	0.000274	0.00189	CcSEcCtD
Terazosin—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000273	0.00188	CcSEcCtD
Terazosin—Pain—Donepezil—Alzheimer's disease	0.000272	0.00187	CcSEcCtD
Terazosin—Constipation—Donepezil—Alzheimer's disease	0.000272	0.00187	CcSEcCtD
Terazosin—Dizziness—Galantamine—Alzheimer's disease	0.000271	0.00187	CcSEcCtD
Terazosin—Hypotension—Memantine—Alzheimer's disease	0.00027	0.00185	CcSEcCtD
Terazosin—Anorexia—Rivastigmine—Alzheimer's disease	0.000269	0.00185	CcSEcCtD
Terazosin—Hypotension—Rivastigmine—Alzheimer's disease	0.000264	0.00181	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000263	0.00181	CcSEcCtD
Terazosin—Feeling abnormal—Donepezil—Alzheimer's disease	0.000262	0.0018	CcSEcCtD
Terazosin—Insomnia—Memantine—Alzheimer's disease	0.000261	0.0018	CcSEcCtD
Terazosin—Vomiting—Galantamine—Alzheimer's disease	0.000261	0.00179	CcSEcCtD
Terazosin—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00026	0.00179	CcSEcCtD
Terazosin—Paraesthesia—Memantine—Alzheimer's disease	0.000259	0.00178	CcSEcCtD
Terazosin—Rash—Galantamine—Alzheimer's disease	0.000259	0.00178	CcSEcCtD
Terazosin—Dermatitis—Galantamine—Alzheimer's disease	0.000258	0.00178	CcSEcCtD
Terazosin—Dyspnoea—Memantine—Alzheimer's disease	0.000257	0.00177	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000257	0.00177	CcSEcCtD
Terazosin—Headache—Galantamine—Alzheimer's disease	0.000257	0.00177	CcSEcCtD
Terazosin—Somnolence—Memantine—Alzheimer's disease	0.000257	0.00176	CcSEcCtD
Terazosin—Insomnia—Rivastigmine—Alzheimer's disease	0.000255	0.00176	CcSEcCtD
Terazosin—Dyspepsia—Memantine—Alzheimer's disease	0.000254	0.00175	CcSEcCtD
Terazosin—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000253	0.00174	CcSEcCtD
Terazosin—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000252	0.00173	CcSEcCtD
Terazosin—Body temperature increased—Donepezil—Alzheimer's disease	0.000251	0.00173	CcSEcCtD
Terazosin—Abdominal pain—Donepezil—Alzheimer's disease	0.000251	0.00173	CcSEcCtD
Terazosin—Somnolence—Rivastigmine—Alzheimer's disease	0.000251	0.00173	CcSEcCtD
Terazosin—Decreased appetite—Memantine—Alzheimer's disease	0.000251	0.00173	CcSEcCtD
Terazosin—Fatigue—Memantine—Alzheimer's disease	0.000249	0.00171	CcSEcCtD
Terazosin—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000248	0.00171	CcSEcCtD
Terazosin—Pain—Memantine—Alzheimer's disease	0.000247	0.0017	CcSEcCtD
Terazosin—Constipation—Memantine—Alzheimer's disease	0.000247	0.0017	CcSEcCtD
Terazosin—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000245	0.00169	CcSEcCtD
Terazosin—Nausea—Galantamine—Alzheimer's disease	0.000244	0.00168	CcSEcCtD
Terazosin—Fatigue—Rivastigmine—Alzheimer's disease	0.000243	0.00167	CcSEcCtD
Terazosin—Pain—Rivastigmine—Alzheimer's disease	0.000241	0.00166	CcSEcCtD
Terazosin—Constipation—Rivastigmine—Alzheimer's disease	0.000241	0.00166	CcSEcCtD
Terazosin—Feeling abnormal—Memantine—Alzheimer's disease	0.000238	0.00164	CcSEcCtD
Terazosin—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000236	0.00162	CcSEcCtD
Terazosin—Hypersensitivity—Donepezil—Alzheimer's disease	0.000234	0.00161	CcSEcCtD
Terazosin—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000233	0.0016	CcSEcCtD
Terazosin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000231	0.00159	CcSEcCtD
Terazosin—Abdominal pain—Memantine—Alzheimer's disease	0.000228	0.00157	CcSEcCtD
Terazosin—Body temperature increased—Memantine—Alzheimer's disease	0.000228	0.00157	CcSEcCtD
Terazosin—Asthenia—Donepezil—Alzheimer's disease	0.000228	0.00157	CcSEcCtD
Terazosin—Pruritus—Donepezil—Alzheimer's disease	0.000225	0.00155	CcSEcCtD
Terazosin—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000223	0.00154	CcSEcCtD
Terazosin—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000223	0.00154	CcSEcCtD
Terazosin—Diarrhoea—Donepezil—Alzheimer's disease	0.000217	0.0015	CcSEcCtD
Terazosin—Hypersensitivity—Memantine—Alzheimer's disease	0.000213	0.00146	CcSEcCtD
Terazosin—Dizziness—Donepezil—Alzheimer's disease	0.00021	0.00145	CcSEcCtD
Terazosin—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000208	0.00143	CcSEcCtD
Terazosin—Asthenia—Memantine—Alzheimer's disease	0.000207	0.00142	CcSEcCtD
Terazosin—Pruritus—Memantine—Alzheimer's disease	0.000204	0.0014	CcSEcCtD
Terazosin—ABCB1—nervous system—Alzheimer's disease	0.000203	0.00595	CbGeAlD
Terazosin—Asthenia—Rivastigmine—Alzheimer's disease	0.000203	0.00139	CcSEcCtD
Terazosin—Vomiting—Donepezil—Alzheimer's disease	0.000202	0.00139	CcSEcCtD
Terazosin—Rash—Donepezil—Alzheimer's disease	0.0002	0.00138	CcSEcCtD
Terazosin—Dermatitis—Donepezil—Alzheimer's disease	0.0002	0.00138	CcSEcCtD
Terazosin—Pruritus—Rivastigmine—Alzheimer's disease	0.0002	0.00137	CcSEcCtD
Terazosin—Headache—Donepezil—Alzheimer's disease	0.000199	0.00137	CcSEcCtD
Terazosin—Diarrhoea—Memantine—Alzheimer's disease	0.000197	0.00136	CcSEcCtD
Terazosin—ABCB1—central nervous system—Alzheimer's disease	0.000195	0.00573	CbGeAlD
Terazosin—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000193	0.00133	CcSEcCtD
Terazosin—Dizziness—Memantine—Alzheimer's disease	0.000191	0.00131	CcSEcCtD
Terazosin—ABCB1—cerebellum—Alzheimer's disease	0.000191	0.0056	CbGeAlD
Terazosin—Nausea—Donepezil—Alzheimer's disease	0.000189	0.0013	CcSEcCtD
Terazosin—Dizziness—Rivastigmine—Alzheimer's disease	0.000187	0.00128	CcSEcCtD
Terazosin—Vomiting—Memantine—Alzheimer's disease	0.000183	0.00126	CcSEcCtD
Terazosin—Rash—Memantine—Alzheimer's disease	0.000182	0.00125	CcSEcCtD
Terazosin—Dermatitis—Memantine—Alzheimer's disease	0.000182	0.00125	CcSEcCtD
Terazosin—Headache—Memantine—Alzheimer's disease	0.000181	0.00124	CcSEcCtD
Terazosin—Vomiting—Rivastigmine—Alzheimer's disease	0.000179	0.00123	CcSEcCtD
Terazosin—Rash—Rivastigmine—Alzheimer's disease	0.000178	0.00122	CcSEcCtD
Terazosin—Dermatitis—Rivastigmine—Alzheimer's disease	0.000178	0.00122	CcSEcCtD
Terazosin—Headache—Rivastigmine—Alzheimer's disease	0.000177	0.00122	CcSEcCtD
Terazosin—Nausea—Memantine—Alzheimer's disease	0.000171	0.00118	CcSEcCtD
Terazosin—Nausea—Rivastigmine—Alzheimer's disease	0.000168	0.00115	CcSEcCtD
Terazosin—ABCB1—brain—Alzheimer's disease	0.000155	0.00455	CbGeAlD
Terazosin—ADRA1B—Signaling by GPCR—SST—Alzheimer's disease	1.77e-05	0.000495	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CRH—Alzheimer's disease	1.74e-05	0.000486	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—SST—Alzheimer's disease	1.73e-05	0.000484	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GAB2—Alzheimer's disease	1.73e-05	0.000484	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—APP—Alzheimer's disease	1.73e-05	0.000482	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	1.72e-05	0.00048	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CCL2—Alzheimer's disease	1.7e-05	0.000475	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CDK5—Alzheimer's disease	1.7e-05	0.000474	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—F2—Alzheimer's disease	1.7e-05	0.000473	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—APP—Alzheimer's disease	1.69e-05	0.000471	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PSENEN—Alzheimer's disease	1.67e-05	0.000466	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.67e-05	0.000466	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	1.66e-05	0.000462	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—NPS—Alzheimer's disease	1.65e-05	0.000461	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APH1A—Alzheimer's disease	1.65e-05	0.00046	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.64e-05	0.000458	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR6—Alzheimer's disease	1.63e-05	0.000456	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PLCB1—Alzheimer's disease	1.63e-05	0.000455	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	1.63e-05	0.000453	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—A2M—Alzheimer's disease	1.62e-05	0.000453	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.62e-05	0.000451	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NCSTN—Alzheimer's disease	1.6e-05	0.000448	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ND1—Alzheimer's disease	1.6e-05	0.000446	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.6e-05	0.000446	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.59e-05	0.000445	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GAB2—Alzheimer's disease	1.58e-05	0.000439	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—SST—Alzheimer's disease	1.58e-05	0.000439	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PSEN2—Alzheimer's disease	1.57e-05	0.000438	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LRP1—Alzheimer's disease	1.56e-05	0.000436	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	1.54e-05	0.000431	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—APP—Alzheimer's disease	1.53e-05	0.000428	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GFAP—Alzheimer's disease	1.53e-05	0.000426	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GAL—Alzheimer's disease	1.53e-05	0.000426	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CCR5—Alzheimer's disease	1.52e-05	0.000423	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CCL2—Alzheimer's disease	1.51e-05	0.000422	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PSENEN—Alzheimer's disease	1.48e-05	0.000414	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.48e-05	0.000414	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APH1A—Alzheimer's disease	1.46e-05	0.000408	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PRKCG—Alzheimer's disease	1.45e-05	0.000405	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PLCB1—Alzheimer's disease	1.45e-05	0.000404	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NPY—Alzheimer's disease	1.45e-05	0.000403	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IAPP—Alzheimer's disease	1.44e-05	0.000401	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	1.43e-05	0.0004	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NCSTN—Alzheimer's disease	1.43e-05	0.000398	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CRH—Alzheimer's disease	1.4e-05	0.000389	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LRP1—Alzheimer's disease	1.39e-05	0.000388	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCR5—Alzheimer's disease	1.38e-05	0.000384	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GFAP—Alzheimer's disease	1.36e-05	0.000379	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GAL—Alzheimer's disease	1.36e-05	0.000379	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR2A—Alzheimer's disease	1.35e-05	0.000376	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—A2M—Alzheimer's disease	1.35e-05	0.000376	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.34e-05	0.000374	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.33e-05	0.00037	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NPS—Alzheimer's disease	1.32e-05	0.000369	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.32e-05	0.000368	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PPP3CA—Alzheimer's disease	1.32e-05	0.000367	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PSEN2—Alzheimer's disease	1.3e-05	0.000364	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—F2—Alzheimer's disease	1.3e-05	0.000363	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTK2B—Alzheimer's disease	1.3e-05	0.000362	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SST—Alzheimer's disease	1.26e-05	0.000352	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GAB2—Alzheimer's disease	1.26e-05	0.000352	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NTRK2—Alzheimer's disease	1.26e-05	0.000352	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CCR5—Alzheimer's disease	1.26e-05	0.000351	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CALM1—Alzheimer's disease	1.26e-05	0.000351	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GSK3A—Alzheimer's disease	1.25e-05	0.000349	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.23e-05	0.000343	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APP—Alzheimer's disease	1.23e-05	0.000343	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.22e-05	0.000339	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PRKCG—Alzheimer's disease	1.21e-05	0.000336	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NPY—Alzheimer's disease	1.2e-05	0.000335	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—A2M—Alzheimer's disease	1.2e-05	0.000334	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IAPP—Alzheimer's disease	1.19e-05	0.000333	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.19e-05	0.000332	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—F2—Alzheimer's disease	1.18e-05	0.000329	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.18e-05	0.000329	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.17e-05	0.000326	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PLCB1—Alzheimer's disease	1.16e-05	0.000324	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PSEN2—Alzheimer's disease	1.16e-05	0.000323	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CRH—Alzheimer's disease	1.16e-05	0.000323	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCR5—Alzheimer's disease	1.14e-05	0.000319	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR2A—Alzheimer's disease	1.12e-05	0.000312	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCR5—Alzheimer's disease	1.12e-05	0.000312	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.12e-05	0.000311	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NPS—Alzheimer's disease	1.1e-05	0.000306	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.09e-05	0.000305	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PPP3CA—Alzheimer's disease	1.09e-05	0.000305	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NGFR—Alzheimer's disease	1.08e-05	0.000302	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—F2—Alzheimer's disease	1.08e-05	0.000301	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTK2B—Alzheimer's disease	1.08e-05	0.0003	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CREB1—Alzheimer's disease	1.08e-05	0.0003	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PRKCG—Alzheimer's disease	1.07e-05	0.000299	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NPY—Alzheimer's disease	1.07e-05	0.000297	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IAPP—Alzheimer's disease	1.06e-05	0.000296	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADAM10—Alzheimer's disease	1.06e-05	0.000295	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCL2—Alzheimer's disease	1.05e-05	0.000294	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SST—Alzheimer's disease	1.05e-05	0.000292	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GAB2—Alzheimer's disease	1.05e-05	0.000292	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NTRK2—Alzheimer's disease	1.05e-05	0.000292	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CALM1—Alzheimer's disease	1.04e-05	0.000291	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.04e-05	0.000291	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GSK3A—Alzheimer's disease	1.04e-05	0.00029	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.03e-05	0.000288	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.03e-05	0.000288	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CRH—Alzheimer's disease	1.03e-05	0.000287	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APP—Alzheimer's disease	1.02e-05	0.000285	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCR5—Alzheimer's disease	1.01e-05	0.000283	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—S100B—Alzheimer's disease	1e-05	0.000279	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR2A—Alzheimer's disease	9.93e-06	0.000277	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MAOB—Alzheimer's disease	9.89e-06	0.000276	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—F2—Alzheimer's disease	9.8e-06	0.000273	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NPS—Alzheimer's disease	9.75e-06	0.000272	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PPP3CA—Alzheimer's disease	9.71e-06	0.000271	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PLCB1—Alzheimer's disease	9.63e-06	0.000269	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—F2—Alzheimer's disease	9.59e-06	0.000267	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTK2B—Alzheimer's disease	9.56e-06	0.000267	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF2—Alzheimer's disease	9.52e-06	0.000266	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GAPDH—Alzheimer's disease	9.52e-06	0.000266	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GAB2—Alzheimer's disease	9.3e-06	0.00026	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SST—Alzheimer's disease	9.3e-06	0.00026	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NTRK2—Alzheimer's disease	9.3e-06	0.00026	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CALM1—Alzheimer's disease	9.27e-06	0.000258	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GSK3A—Alzheimer's disease	9.22e-06	0.000257	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF1R—Alzheimer's disease	9.21e-06	0.000257	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—A2M—Alzheimer's disease	9.19e-06	0.000256	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	9.19e-06	0.000256	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	9.07e-06	0.000253	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NGFR—Alzheimer's disease	8.99e-06	0.000251	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CREB1—Alzheimer's disease	8.93e-06	0.000249	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LPL—Alzheimer's disease	8.83e-06	0.000246	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADAM10—Alzheimer's disease	8.78e-06	0.000245	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MEF2C—Alzheimer's disease	8.75e-06	0.000244	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL2—Alzheimer's disease	8.74e-06	0.000244	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	8.71e-06	0.000243	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRKCG—Alzheimer's disease	8.58e-06	0.000239	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	8.56e-06	0.000239	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NGF—Alzheimer's disease	8.36e-06	0.000233	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—S100B—Alzheimer's disease	8.3e-06	0.000232	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCR5—Alzheimer's disease	8.13e-06	0.000227	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ACHE—Alzheimer's disease	8e-06	0.000223	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	7.98e-06	0.000223	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR2A—Alzheimer's disease	7.96e-06	0.000222	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	7.93e-06	0.000221	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—INPP5D—Alzheimer's disease	7.91e-06	0.000221	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF2—Alzheimer's disease	7.9e-06	0.00022	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	7.8e-06	0.000218	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	7.76e-06	0.000217	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	7.76e-06	0.000217	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF1R—Alzheimer's disease	7.64e-06	0.000213	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ENO1—Alzheimer's disease	7.49e-06	0.000209	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS1—Alzheimer's disease	7.49e-06	0.000209	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CALM1—Alzheimer's disease	7.43e-06	0.000207	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LEP—Alzheimer's disease	7.4e-06	0.000206	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOE—Alzheimer's disease	7.4e-06	0.000206	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	7.37e-06	0.000206	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	7.35e-06	0.000205	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CAV1—Alzheimer's disease	7.33e-06	0.000204	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LPL—Alzheimer's disease	7.33e-06	0.000204	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MEF2C—Alzheimer's disease	7.26e-06	0.000203	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKCG—Alzheimer's disease	7.12e-06	0.000199	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ESR1—Alzheimer's disease	7.06e-06	0.000197	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	7.02e-06	0.000196	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—F2—Alzheimer's disease	6.98e-06	0.000195	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—BCHE—Alzheimer's disease	6.97e-06	0.000194	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NGF—Alzheimer's disease	6.94e-06	0.000194	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOTCH1—Alzheimer's disease	6.83e-06	0.00019	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	6.79e-06	0.000189	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCR5—Alzheimer's disease	6.75e-06	0.000188	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR2A—Alzheimer's disease	6.61e-06	0.000184	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PLCB1—Alzheimer's disease	6.57e-06	0.000183	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	6.51e-06	0.000182	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	6.45e-06	0.00018	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GSK3B—Alzheimer's disease	6.41e-06	0.000179	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ABCA1—Alzheimer's disease	6.37e-06	0.000178	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CREB1—Alzheimer's disease	6.36e-06	0.000177	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	6.33e-06	0.000177	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—INS—Alzheimer's disease	6.32e-06	0.000176	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL2—Alzheimer's disease	6.22e-06	0.000173	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	6.16e-06	0.000172	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	6.16e-06	0.000172	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	6.14e-06	0.000171	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	6.14e-06	0.000171	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF1—Alzheimer's disease	6.11e-06	0.000171	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	6.08e-06	0.00017	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	6e-06	0.000167	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	5.87e-06	0.000164	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	5.86e-06	0.000164	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	5.79e-06	0.000162	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	5.67e-06	0.000158	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOS3—Alzheimer's disease	5.54e-06	0.000155	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	5.49e-06	0.000153	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	5.47e-06	0.000153	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HMOX1—Alzheimer's disease	5.47e-06	0.000153	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	5.45e-06	0.000152	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	5.45e-06	0.000152	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	5.4e-06	0.000151	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	5.32e-06	0.000148	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	5.28e-06	0.000147	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	5.25e-06	0.000146	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	5.21e-06	0.000145	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	5.16e-06	0.000144	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	5.14e-06	0.000143	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	5.07e-06	0.000142	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.03e-06	0.00014	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LPL—Alzheimer's disease	5e-06	0.000139	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	4.75e-06	0.000132	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	4.72e-06	0.000132	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	4.71e-06	0.000131	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	4.69e-06	0.000131	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	4.68e-06	0.00013	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	4.66e-06	0.00013	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	4.6e-06	0.000128	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	4.59e-06	0.000128	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	4.51e-06	0.000126	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MTHFR—Alzheimer's disease	4.5e-06	0.000126	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	4.33e-06	0.000121	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	4.31e-06	0.00012	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CALM1—Alzheimer's disease	4.21e-06	0.000117	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOE—Alzheimer's disease	4.19e-06	0.000117	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAV1—Alzheimer's disease	4.15e-06	0.000116	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	4.09e-06	0.000114	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	3.99e-06	0.000111	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.94e-06	0.00011	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	3.91e-06	0.000109	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	3.88e-06	0.000108	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	3.67e-06	0.000102	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARG—Alzheimer's disease	3.65e-06	0.000102	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	3.59e-06	0.0001	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—INS—Alzheimer's disease	3.58e-06	9.99e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	3.58e-06	9.99e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.5e-06	9.77e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	3.47e-06	9.68e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	3.45e-06	9.62e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	3.31e-06	9.25e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	3.19e-06	8.89e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	3.18e-06	8.87e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NOS3—Alzheimer's disease	3.14e-06	8.76e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	3.04e-06	8.49e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	3.02e-06	8.42e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.94e-06	8.21e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.87e-06	8.01e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	2.76e-06	7.7e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.7e-06	7.54e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	2.55e-06	7.11e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	2.5e-06	6.99e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	2.29e-06	6.39e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	2.22e-06	6.21e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	2.11e-06	5.9e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	2.04e-06	5.68e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.88e-06	5.24e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.44e-06	4.03e-05	CbGpPWpGaD
